In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...